News summary
enhua pharmaceuticalmajesticgoldmegaways: Notice of approval for alfentanil hydrochloride injection for drug supplement application Securities Times e Company NewsmajesticgoldmegawaysEnhua Pharmaceutical (002262) announced on the evening of April 29 that the company recently received a drug supplement application for alfentanil hydrochloride injection approved and issued by the State Food and Drug Administrationmajesticgoldmegaways...
Newsletter text
Enhua Pharmaceutical: Alfentanil Hydrochloride Injection received approval notice for drug supplement application. Securities Times e Company News, Enhua Pharmaceutical (002262) announced on the evening of April 29 that the company recently received approval from the State Drug Administration. The approval notice for drug supplement application for alfentanil Hydrochloride Injection approved the increase of 5ml of the drugmajesticgoldmegaways:2.5mg strength. Alfentanil hydrochloride injection is an opioid receptor agonist used as a narcotic analgesic for the induction and maintenance of general anesthesia.